Skip to content

Absci Corporation ABSI Net Investment in Lease

Net Investment in Lease at other companies

Schrodinger logo
SchrodingerSDGR
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
ADMA Biologics logo
ADMA BiologicsADMA
Precigen logo
PrecigenPGEN

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+43.6%
Enterprise value$1.57B+73.1%
P/S855.5×+628×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's net investment in lease?
Absci Corporation (ABSI) reported net investment in lease of $2.63M in Q1 2026.
How has Absci Corporation's net investment in lease changed year-over-year?
Absci Corporation's net investment in lease decreased by 29.2% year-over-year, from $3.72M to $2.63M.
What is the long-term trend for Absci Corporation's net investment in lease?
Over 5 years (2020 to 2025), Absci Corporation's net investment in lease has grown at a -8.2% compound annual growth rate (CAGR), from $4.48M to $2.91M.